• Notice

Call for Participants [Conference on Super-Different Fields] Thinking about Human Health in Intestines and Different Fields / March 5, 2021, 16:00-@Ota-ku, Tokyo

2021.01.27
Recruitment of participants for [Conference on Super-Disciplinarity] Human Health in Gut and Different Fields / March 5, 2021, 16:00-@Ota-ku.
panel discussion
Human Health in the Gut and Different Fields


A panel discussion, "Considering Human Health in the Gut and Different Fields" (session partner: Daicel Corporation), will be held within the 10th Annual Conference of the Society of Hyperdifferent Fields, sponsored by LIVANES (March 5-6, 2021 (Friday and Saturday)).

Registration for auditing has closed.

 

In this session, experts in food and mucosal immunity and data analysis will be invited to discuss the relationship between food, the intestinal environment, and the human condition. Both are multi-component systems, and in order to unravel these complex relationships and realize health from the gut, we expect to see the entry of science and technology from even more different fields. We look forward to viewing researchers from all fields of life sciences, science, mathematics, and engineering.

 

We will have a program of discussions among researchers, start-ups, and large companies from a variety of perspectives, not limited to the themes of this session.
We are now accepting applications for audience participation, poster presentations, and booth exhibitors.
The information is available on the convention website (see below).

The 10th Main Meeting of the Association of Hyperdifferent Fields WEB
*The event will be held after taking measures against new coronavirus infection on the day of the event.For more information

 


Human Health in the Gut and Different Fields
Session Partner: Daicel Corporation
Date: Friday, March 5, 202116:00-17:00
Location: Congress Square Haneda (Haneda Innovation City Zone J, 1-1-4 Haneda Airport, Ota-ku, Tokyo)

Details:https://hic.lne.st/conference/hic2021/

 

 

speaker

Daicel Corporation
Healthcare SBU Business Promotion Office
Manager, Business Strategy Group
Yuichi Ukawa

After completing a master's degree in agriculture, he worked for a paper/pulp manufacturer, a beverage manufacturer, and a food manufacturer before joining Daicel Corporation in September 2018. Assigned to the research department, he is responsible for obtaining evidence for the company's functional food ingredients, preparing materials for functional food labeling, and conducting industry association activities, etc. He has been in his current position since April 2020. He is in charge of business strategy, marketing strategy, and research planning for new and existing ingredients. He also serves as Vice-Chairman of the Technical Committee of the Food for Specified Health Use Department of the Japan Health and Nutrition Food Association, and Director and Efficacy Working Group Leader of the Health and Food Roundtable, and is involved in activities aimed at the development of the health food industry. D. (Health Science), Professional Engineer (Biotechnology), Certified Food Health Instructor, and Specialized Food Specialist.

Humanome Research Institute, Inc.
President and Representative Director
Jun Sese

D. in Science, Graduate School of Frontier Sciences, The University of Tokyo. D. in Science, Graduate School of Frontier Sciences, The University of Tokyo, and has served as Assistant Professor at the University of Tokyo, Associate Professor at Ochanomizu University, Associate Professor at Tokyo Institute of Technology, and Research Team Leader at the National Institute of Advanced Industrial Science and Technology (AIST). He specializes in the development of machine learning and mathematical statistics methods and large-scale data analysis in the life sciences. He won the KDD Cup 2001, a data mining contest of the American Society for Computing Machinery, and the Oxford Journals-JSBi Prize.

National Institute of Biomedical Innovation
Vaccine and Adjuvant Research Center
center director
Jun Kunisawa

Graduated from the Faculty of Pharmaceutical Sciences, Osaka University in 1996, and received his Doctor of Pharmacy (Osaka University) in 2001. After studying at the University of California, Berkeley, he became an assistant professor at the Institute of Medical Science, University of Tokyo in 2004. After working as an assistant professor, lecturer, and associate professor at the same institute, he became a project leader at his current affiliation in 2013, and will be the director of his current center in 2019. Other appointments include: visiting professor at the Institute of Medical Science, University of Tokyo; invited professor at the Graduate Schools of Medicine, Pharmaceutical Sciences, and Dentistry, Osaka University (affiliated graduate school); visiting professor at the Graduate School of Medicine, Kobe University (affiliated graduate school); visiting professor at the School of Dentistry, Hiroshima University; and visiting professor at the Nano-Life Innovation Research Organization, Waseda University.

.
Representative Director, Vice President CTO, Liverness, Inc.
Jyo Inoue

D. in Pharmaceutical Sciences from Tokyo University of Pharmacy and Life Sciences. He is a founding member of LIVERNESS. After completing the doctoral program, he worked as an assistant professor and lecturer at the Faculty of Science, Kitasato University, and as an assistant professor at the Graduate School of Medicine, Kyoto University before becoming a specially-appointed associate professor at the Institute for Advanced Biosciences, Keio University in 2015 and a professor at the Faculty of Pharmaceutical Sciences, Kumamoto University in 2018. While conducting research and development, he is a researcher involved in launching joint research projects with universities and research institutions and supporting the establishment of research institutes.

 

The 10th Main Conference of the Association of Hyperdifferent Fields (Registration period has ended)

 

en_USEnglish